Unsolicited applications. We are always looking for talented and motivated people. The unknown aspects of the extracellular matrix (ECM) have always fascinated Diana Julie Leeming. Initially, she worked with ECM markers for bone remodeling during her PhD. Industrial PhD project within Non-alcoholic fatty liver disease.

Biomarker and Research division is focused on development of new biochemical markers for diagnosis and prognosis of various diseases.

The Clinical Development division is a CRO . The project is anchored in the cross field between clinical and basic research. The basis for the PhD project is the Prospective Epidemiologic Risk Factor (PERF) Study, which is a clinical study approved by the ethics committee of the . Under the collaboration— whose value was not disclosed—the companies agreed to develop . They develop tools to measure specific substances in blood and urine. These substances are indicative of a disease, when present . Biologics World Nordic.

Do you want to know more about the Copenhagen Bioscience PhD programme? Christiansen co-founded SYNARC Inc.

Chairman and Chief Executive Officer. Human embryonic stem cell-derived hepatocytes as in vitro pharmacokinetic model. Enterprise: Cellartis AB, Sweden. Nordic Bioscience is a partner in the DevelopAKUre consortium.

PhD research for industrialization of thin films for . What are you waiting for? University: University of Oslo, Norway. You will play a pivotal role in development and validation of serological biomarkers for diagnosis and prognosis of NASH in animal models as well as in clinical samples. The Laboratory division offers a complete portfolio of central . Charles River company, announced today a collaboration to improve the research and development of therapeutic approaches in multi- organ fibrosis. Richard Lyttle, PhD , President and Chief Executive Officer of Radius.

When assessing cancer risk, body mass . Morten Karsdal received his Ph.